Definition of metyrapone in English:

metyrapone

noun mɪˈtɪrəpəʊnmɪˈtʌɪrəpəʊn

Pharmacology

A compound that inhibits the enzyme 17β-hydroxylase and prevents synthesis of glucocorticoids and mineralocorticoids by the adrenal gland, used chiefly for assessment of feedback control of the hypothalamic-pituitary axis in adrenal disease, and sometimes in the treatment of Cushing's syndrome and resistant oedema; 2-methyl-1,2-di-3-pyridyl-1-propanone, C₅H₄N·CO·C(CH₃)₂·C₅H₄N.

Origin

1960s; earliest use found in The Lancet. Probably from met- + -yr- + -a- connective + -p- + -one.

Definition of metyrapone in US English:

metyrapone

noun

Pharmacology

A compound that inhibits the enzyme 17β-hydroxylase and prevents synthesis of glucocorticoids and mineralocorticoids by the adrenal gland, used chiefly for assessment of feedback control of the hypothalamic-pituitary axis in adrenal disease, and sometimes in the treatment of Cushing's syndrome and resistant oedema; 2-methyl-1,2-di-3-pyridyl-1-propanone, C₅H₄N·CO·C(CH₃)₂·C₅H₄N.

Origin

1960s; earliest use found in The Lancet. Probably from met- + -yr- + -a- connective + -p- + -one.

单词	metyrapone
释义	Definition of metyrapone in English: metyrapone noun mɪˈtɪrəpəʊnmɪˈtʌɪrəpəʊn Pharmacology A compound that inhibits the enzyme 17β-hydroxylase and prevents synthesis of glucocorticoids and mineralocorticoids by the adrenal gland, used chiefly for assessment of feedback control of the hypothalamic-pituitary axis in adrenal disease, and sometimes in the treatment of Cushing's syndrome and resistant oedema; 2-methyl-1,2-di-3-pyridyl-1-propanone, C₅H₄N·CO·C(CH₃)₂·C₅H₄N. Origin 1960s; earliest use found in The Lancet. Probably from met- + -yr- + -a- connective + -p- + -one. Definition of metyrapone in US English: metyrapone noun Pharmacology A compound that inhibits the enzyme 17β-hydroxylase and prevents synthesis of glucocorticoids and mineralocorticoids by the adrenal gland, used chiefly for assessment of feedback control of the hypothalamic-pituitary axis in adrenal disease, and sometimes in the treatment of Cushing's syndrome and resistant oedema; 2-methyl-1,2-di-3-pyridyl-1-propanone, C₅H₄N·CO·C(CH₃)₂·C₅H₄N. Origin 1960s; earliest use found in The Lancet. Probably from met- + -yr- + -a- connective + -p- + -one.
随便看	extemporaneous extemporaneously extemporaneously extemporaneousness extemporaneousness extemporarily extemporarily extemporariness extemporariness extemporary extempore extemporisation extemporisations extemporise extemporised extemporising extemporization extemporization extemporize extemporized extemporizer extemporizes extemporizing extend extendability